About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
SIVB - SVB Financial Group| Previous Close | $285.06 | Open | $291.99 |
| Volume | 684.4K | Market Cap | 14.755B |
| Yield | Last Dividend |
| Insider Selling: SVB Financial Group (NA... | 3:44 AM |
| SVB Financial Group (NASDAQ:SIVB) insider Michael Descheneaux sold 1,495 shares of SVB Financial Group stock in a transaction on Tuesday, October 20th... | |
| Amgen Inc. Expected to Post FY2022 Earni... | 10/24/20 |
| Amgen Inc. (NASDAQ:AMGN) ??? Analysts at SVB Leerink dropped their FY2022 earnings estimates for Amgen in a report issued on Wednesday, October 21st. ... | |
| FY2020 EPS Estimates for Sanofi SA Reduc... | 10/24/20 |
| Sanofi SA (NYSE:SNY) ??? Equities researchers at SVB Leerink dropped their FY2020 earnings per share estimates for Sanofi in a research report issued ... | |
| SVB Financial Group (NASDAQ:SIVB) Releas... | 10/24/20 |
| SVB Financial Group (NASDAQ:SIVB) issued its quarterly earnings data on Thursday. The bank reported $8.47 earnings per share for the quarter, beating ... | |
| Q3 2020 Earnings Estimate for Amneal Pha... | 10/24/20 |
| Amneal Pharmaceuticals, Inc. (NYSE:AMRX) ??? Equities researchers at SVB Leerink reduced their Q3 2020 EPS estimates for Amneal Pharmaceuticals in a r... | |
| Q3 2020 Earnings Estimate for Endo Inter... | 10/24/20 |
| Endo International PLC (NASDAQ:ENDP) (TSE:ENL) ??? Equities research analysts at SVB Leerink raised their Q3 2020 earnings per share estimates for End... | |
| Q3 2020 Earnings Estimate for Mylan (NAS... | 10/24/20 |
| Mylan (NASDAQ:MYL) ??? Analysts at SVB Leerink increased their Q3 2020 EPS estimates for shares of Mylan in a research note issued on Tuesday, October... | |
| SVB Financial releases reserves, citing ... | 10/23/20 |
| The company's Silicon Valley Bank unit released $52 million in reserves and says more private-equity and VC clients are warming to the practice of doi... | |
| Exact Sciences (NASDAQ:EXAS) Hits New 52... | 10/23/20 |
| Shares of Exact Sciences Co. (NASDAQ:EXAS) hit a new 52-week high during trading on Friday . The company traded as high as $110.77 and last traded at ... | |
| FY2020 EPS Estimates for Abbott Laborato... | 10/23/20 |
| Abbott Laboratories (NYSE:ABT) ??? Equities researchers at SVB Leerink increased their FY2020 earnings estimates for Abbott Laboratories in a research... | |
| SVB Financial Group (NASDAQ:SIVB) Stock ... | 10/23/20 |
| SVB Financial Group (NASDAQ:SIVB) was upgraded by equities researchers at BidaskClub from a ???buy??? rating to a ???strong-buy??? rating in a researc... | |
| FY2020 EPS Estimates for Mylan (NASDAQ:M... | 10/23/20 |
| Mylan (NASDAQ:MYL) ??? Research analysts at SVB Leerink increased their FY2020 EPS estimates for shares of Mylan in a report issued on Tuesday, Octobe... | |
| SVB Leerink Comments on Pacira Bioscienc... | 10/22/20 |
| Pacira Biosciences Inc (NASDAQ:PCRX) ??? Equities researchers at SVB Leerink upped their FY2020 earnings estimates for Pacira Biosciences in a report ... | |
| Ardelyx Inc (NASDAQ:ARDX) Forecasted to ... | 10/22/20 |
| Ardelyx Inc (NASDAQ:ARDX) ??? SVB Leerink upped their Q3 2020 EPS estimates for Ardelyx in a research note issued on Tuesday, October 20th. SVB Leerin... | |
| Q3 2020 EPS Estimates for Gilead Science... | 10/22/20 |
| Gilead Sciences, Inc. (NASDAQ:GILD) ??? Research analysts at SVB Leerink dropped their Q3 2020 earnings per share estimates for Gilead Sciences in a r... | |
| Q3 2020 Earnings Forecast for Mylan Issu... | 10/22/20 |
| Mylan (NASDAQ:MYL) ??? Equities research analysts at SVB Leerink lifted their Q3 2020 earnings per share (EPS) estimates for shares of Mylan in a repo... | |
| Michael Descheneaux Sells 1,495 Shares o... | 10/22/20 |
| SVB Financial Group (NASDAQ:SIVB) insider Michael Descheneaux sold 1,495 shares of the firm???s stock in a transaction on Tuesday, October 20th. The s... | |
| Brokers Offer Predictions for AbbVie Inc... | 10/22/20 |
| AbbVie Inc. (NYSE:ABBV) ??? Equities research analysts at SVB Leerink reduced their Q3 2020 earnings estimates for AbbVie in a research note issued on... | |
| Q3 2020 Earnings Estimate for Teva Pharm... | 10/22/20 |
| Teva Pharmaceutical Industries Limited (NYSE:TEVA) ??? Research analysts at SVB Leerink cut their Q3 2020 earnings per share (EPS) estimates for share... | |
| Vericel Co. to Post Q1 2022 Earnings of ... | 10/22/20 |
| Vericel Co. (NASDAQ:VCEL) ??? Equities researchers at SVB Leerink issued their Q1 2022 earnings estimates for shares of Vericel in a research note iss... | |
| Mylan to Post FY2020 Earnings of $4.60 P... | 10/21/20 |
| Mylan (NASDAQ:MYL) ??? Research analysts at SVB Leerink raised their FY2020 earnings estimates for shares of Mylan in a note issued to investors on Tu... | |
| Analysts Offer Predictions for Amneal Ph... | 10/21/20 |
| Amneal Pharmaceuticals, Inc. (NYSE:AMRX) ??? SVB Leerink increased their Q4 2020 EPS estimates for shares of Amneal Pharmaceuticals in a note issued t... | |
| FY2020 Earnings Forecast for Mylan Issue... | 10/21/20 |
| Mylan (NASDAQ:MYL) ??? Equities researchers at SVB Leerink boosted their FY2020 earnings per share (EPS) estimates for shares of Mylan in a report iss... | |
| Q4 2020 EPS Estimates for UnitedHealth G... | 10/21/20 |
| UnitedHealth Group Inc (NYSE:UNH) ??? SVB Leerink decreased their Q4 2020 earnings per share (EPS) estimates for shares of UnitedHealth Group in a rep... | |
| Q4 2020 EPS Estimates for REGENXBIO Inc.... | 10/21/20 |
| REGENXBIO Inc. (NASDAQ:RGNX) ??? Investment analysts at SVB Leerink increased their Q4 2020 EPS estimates for shares of REGENXBIO in a research report... | |
| SVB Leerink Comments on BioNTech SE???s ... | 10/21/20 |
| BioNTech SE (NASDAQ:BNTX) ??? SVB Leerink dropped their Q3 2020 earnings per share estimates for shares of BioNTech in a note issued to investors on W... | |
| Scholar Rock Secures $50 million Debt Fa... | 10/19/20 |
| CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious disease... | |
| Silicon Valley Bank Kicks Off 10th Annua... | 10/05/20 |
| SANTA CLARA, Calif., Oct. 5, 2020 /PRNewswire/ -- Silicon Valley Bank (SVB), the bank of the world's most innovative companies and their investors, to... | |
| Geron Secures Loan Facility for Up to $7... | 10/01/20 |
| FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that it has e... | |
| Exicure Secures Debt Facility for Up to ... | 10/01/20 |
| CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure today announced it has entered into a $25.0 million senior secured term loan with MidCap Financia... | |
| Strong Buy rating | 10/23/20 |
| Raymond James maintains Outperform rating and raises Price Target from $297.00 to $325.00 | |
| Strong Buy rating | 09/03/20 |
| Raymond James maintains Outperform rating and raises Price Target from $260.00 to $297.00 | |
| Strong Buy rating | 08/04/20 |
| Morgan Stanley maintains Overweight rating and raises Price Target from $260.00 to $275.00 | |
| Date | 2020-10-22 (AMC) | Est. (EPS/Rev.) | $5.14/ 888.6M |
| Actual (EPS/Rev.) | $8.47/ $1.08 B | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| TopFlight Trades - Premium (Options) | Eric Cunningham | 51.00 % | Follow |
| TopFlight Trades - Premium (Stocks) | Eric Cunningham | 38.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
